Edward Greeno's primary interest is in treatment of gastrointestinal malignancies, including rare tumor types such as neuroendocrine tumors and appendix cancer. He is an investigator on numerous therapeutic trials for gastrointestinal cancers ranging from large multinational trials which have led to the approval of new treatments, to first in human trials of new agents developed at the University of Minnesota.